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Introduction
The definition of metabolic syndrome (MS) helps to
identify people at risk for cardiovascular diseases in the
western world1–4 as well as in Taiwan5,6. Recent studies
showed that the prevalence of MS among a number of
Asian populations has been increasing rapidly7,8. How-
ever, the criteria used by different countries are not the
same. Since the introduction of five components for
MS in 2001 by the National Cholesterol Education Pro-
gram9, major changes in the evolution of the MS crite-
ria defined by different societies/organizations have
lowered the cutoff point for fasting glucose and the
ethnic-specific cutoff point of waist circumference for
central (abdominal) obesity10,11. In addition, the criteria
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SUMMARY
Background: The cutoff of abdominal circumference for metabolic syndrome (MS) defined by the Bureau of
Health Promotion (BHP) of Taiwan for Taiwanese (men, 90 cm; women, 80 cm) and by the International
Diabetes Federation (IDF) for Japanese (men, 85 cm; women, 90 cm) differs. This study aimed to examine the
impact of this difference on the prevalence of MS and the impact of an MS diagnosis on the projected risk of
stroke in hypertensive Taiwanese.
Methods: MS was examined in a sample of 3,472 hypertensive patients (aged 55–80 years; 1,709 women)
across Taiwan. The 10-year probability of stroke estimated from the Framingham equation was compared
between MS and non-MS patients.
Results: The prevalence of MS using the BHP criteria was 59.2% using the BHP criteria (95% confidence interval,
CI, 57.6–60.8%; men, 52.5%; women, 66.1%) and 48.9% by the IDF criteria (95% CI, 47.2–50.5%; men, 61.3%;
women, 36.1%). Both criteria showed that, compared with non-MS, MS has higher predicted 10-year probabil-
ity of stroke (BHP, 0.153 ± 0.115 vs. 0.133 ± 0.105; IDF, 0.159 ± 0.109 vs. 0.132 ± 0.112; both p < 0.001) because of
the difference in women (BHP, 0.143 ± 0.124 vs. 0.102 ± 0.091; IDF, 0.147 ± 0.121 vs. 0.118 ± 0.110; both
p < 0.001) rather than men (BHP, p = 0.21; IDF, p = 0.29).
Conclusion: Both criteria demonstrate that MS is highly prevalent in elderly hypertensive patients in Taiwan.
Additionally in women, but not men, the predicted probability of stroke is higher in MS than in non-MS
patients. The diagnosis of MS is potentially useful for identifying elderly hypertensive females with an elevated
risk of stroke in Taiwan. [International Journal of Gerontology 2009; 3(4): 233–240]
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updated by the International Diabetes Federation (IDF)
in 2005 emphasized central obesity as a mandatory
component10. For the same population at the same
time period when the cutoff point for fasting glucose
is lowered, the prevalence of MS should increase, but
the relative risk of MS to predict cardiovascular diseases
may decrease. However, the effects of ethnic-specific
criteria for waist circumference on the prevalence of
MS and the impact of an MS diagnosis on the pro-
jected risk for stroke in elderly hypertensive patients
remain unclear.
Geographically, Taiwan and Japan are close and have
similar cultures, in terms of food and lifestyle, which
are intimately linked to the pathogenesis of cardiovas-
cular disease. In addition, in both countries, the burden
of cerebrovascular disease exceeds that of ischemic
heart disease. However, the 2005 IDF cutoff point of
waist circumference for central obesity varies between
the two countries12. In addition, the official criteria cur-
rently used in Taiwan do not consider central obesity a
mandatory component. Since age and hypertension
are well-known risk factors for stroke and MS has been
shown useful for risk stratification of cardiovascular
disease13, it is important to examine which criteria of
MS predicts stroke better in elderly people with hyper-
tension. To this end, we compared the prevalence of MS,
the risk factor distribution, and the projected probabil-
ity of stroke using the Framingham equation14 in eld-
erly hypertensive Taiwanese between the two criteria.
Methods
The study protocol conforms to the ethical guidelines of
the 1975 Declaration of Helsinki as reflected in a priori
approval by the Joint Institution Review Board, Taiwan.
Informed consent was obtained from each patient.
Subjects
From November 2005 to July 2006, a total of 3,775
patients participating in the LIFE in life survey consti-
tuted the database of this study. Entry criteria into the
survey included men or women who were Taiwanese
residents, aged 55–80 years, and had been diagnosed
hypertension, and were routinely taking antihyperten-
sive medications, or with objective evidence of target
organ damages. Patients were excluded from the survey
if they had secondary hypertension of any etiology. All
participants were receiving care in the outpatient
department of 35 study sites, including eight medical
centers, 19 regional hospitals and eight area hospitals,
and involving 24 cardiology specialists, 13 neurology
specialists and one internist. At each site, participants
were randomly selected by the doctor from his/her
outpatient hypertensive patient pool.
Data collection
Baseline characteristic data, including sex and age, and
duration of hypertension or antihypertensive therapy
as well as other medication and exercise habit were col-
lected. Height, weight, waist circumference, and blood
pressure were measured. Heart murmur and carotid
bruit were checked. All participants underwent stan-
dard 12-lead electrocardiographic examination. Over-
night fasting blood was analyzed to determine the levels
of sugar, high-density lipoprotein (HDL)-cholesterol,
triglycerides, uric acid, and creatinine, all of which were
examined no earlier than 3 months before the enroll-
ment. Traditional cardiovascular risk factors, includ-
ing smoking, diabetes and family history of premature
cardiovascular disease, were sought. In addition, pre-
vious diagnoses of stroke and/or transient ischemic
attack, congestive heart failure, myocardial infarction,
angina, murmur, left ventricular hypertrophy, and atrial
fibrillation were recorded.
Comparison of risk burden according to different
MS criteria
The presence of MS was defined by the Bureau of Health
Promotion (BHP), Department of Health, Taiwan, accord-
ing to the current Taiwan criteria updated in 2007,
which require three or more of the five components
listed below, and by the International Diabetes Federa-
tion (IDF) for Japanese, as announced in 2005 using
central obesity as a mandatory component plus two
other components. The presence of central obesity ac-
cording to the BHP definition is a waist circumference
≥ 90 cm for men and ≥ 80 cm for women, in contrast to
≥ 85 cm for men and ≥ 90 cm for women by the IDF de-
finition (Table 1). All the other cutoff points are the same
and are as follows: (1) fasting glucose ≥ 100 mg/dL or
use of antidiabetic drugs; (2) HDL-cholesterol <40mg/dL
for men and < 50 mg/dL for women; and (3) triglyc-
erides ≥ 150 mg/dL. For blood pressure, all the en-
rolled subjects had hypertension or were treated with
antihypertensive drugs. The 10-year probabilities of
stroke, estimated from the Framingham study14, were
compared between MS and non-MS patients using both
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the BHP and IDF criteria. Information regarding the risk
equation, the broad study subject characteristics, locale
of Framingham participants, and time period when the
risk equation was developed has been published14,15.
Statistical analysis
Statistical analyses were performed using SAS version
8.2 (SAS Institute, Cary, NC, USA). Data are presented as
mean ± standard deviation for continuous variables
and proportions for categorical variables. The differ-
ence in mean continuous variables between patients
with and without MS was compared using two sample
t tests. The comparison of proportions between groups
was performed using χ2 test. For all tests, two-tailed
p < 0.05 was required for statistical significance.
Results
In the 3,775 persons registered in the present survey,
303 persons were not in the age range of 55–80 years,
leaving 3,472 persons (1,709 women) to enter the final
analysis. Of them, 932 (26.8%) were cared for at med-
ical centers, 1,881 (54.2%) at regional hospitals, and 659
(19.0%) at area hospitals. Regarding their care providers,
2,285 (65.8%) were cared for by cardiology specialists,
1,089 (31.4%) by neurology specialists, and 98 (2.8%)
by internists. There was an even age and sex distribu-
tion; 1,763 (50.8%) were men and the percentages of
participants in each 5-year age section was approxi-
mately 20% (17.7–22.8%).
The components distribution and the prevalence
of MS are shown in Table 1. As a whole, the BHP crite-
ria defined 59.2% (95% confidence interval, CI,
57.6–60.8%) and the IDF criteria defined 48.9% (95%
CI, 47.2–50.5%) of the study population with MS. When
each component of MS was taken into account, signif-
icant sex differences were found for central obesity,
defined by either the BHP or IDF cutoff point (both
p < 0.001). In addition, the level of HDL-cholesterol var-
ied between men and women (p < 0.001). As expected,
while the BHP cutoff point defined more central obe-
sity in women (81.3%) than men (62.2%), the IDF cutoff
point has a reverse result. More central obesity in men
(82.8%) was found compared with women (44.2%).
Apart from the central obesity, although more women
had a level of HDL-cholesterol below the sex-specific
cutoff point than men (41.2% vs. 29.7%), the mean 
levels were higher in women (54.2 ± 14.1 mg/dL vs.
46.9 ± 12.6 mg/dL; p < 0.001). For both sexes, more
than one-third had high triglyceride levels, and about
two-thirds had high glucose levels. As a result and sim-
ilar to the sex difference in central obesity, the BHP
criteria defined more MS in women (66.1%; 95% CI,
63.9–68.4%) than men (52.5%; 95% CI, 50.1–54.8%),
while the IDF criteria defined more men (61.3%; 95%
CI, 59.0–63.5%) than women (36.1%; 95% CI, 33.8–
38.4%). The sex difference of MS prevalence defined by
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Table 1. Components distribution and prevalence of metabolic syndrome (MS)*
Men Women Total 
p
(n = 1,763) (n = 1,709) (n = 3,472)
Abdominal circumference†
BHP (men, ≥ 90 cm; women, ≥ 80 cm) 62.2 81.3 71.6 < 0.001
IDF (men, ≥ 85 cm; women, ≥ 90 cm) 82.8 44.2 63.7 < 0.001
Triglyceride ≥ 150 mg/dL‡ 35.7 40.2 37.9 0.11
HDL-cholesterol (men, < 40 mg/dL; 29.7 41.2 35.5 < 0.001
women, < 50 mg/dL)§
Systolic BP ≥ 130 mmHg or diastolic BP ≥ 85 mmHg, 100 100 100
or current use of antihypertensive drugs
Fasting blood sugar ≥ 100 mg/dL 64.5 66.6 65.6 0.20
MS definition
BHP (any three of above five components) 52.5 66.1 59.2 < 0.001
IDF (central obesity plus any two of the 61.3 36.1 48.9 < 0.001
other four components)
*Data are presented as percentage; †data available in 1,748 men and 1,701 women; ‡data available in 575 men and 562 women; §data avail-
able in 1,172 men and 1,198 women; data available in 1,734 men and 1,681 women. BHP = Bureau of Health Promotion; IDF = International
Federation of Diabetes; BP = blood pressure.
each of the two criteria reaches statistical significance
(both p < 0.001).
The distribution of risk factors is shown in Table 2.
For history of angina and diabetes, both criteria showed
that each of the risk factors was significantly more fre-
quently seen in people with MS than those without
MS. For congestive heart failure and heart murmur,
although both criteria demonstrated that the percent-
age for each risk factor was higher in people with MS
than those without MS, the difference did not reach
statistical significance. For myocardial infarction and
cerebrovascular disease and/or transient ischemic at-
tack, both criteria demonstrated that the percentage of
each risk factor in people with MS was higher than those
without MS, but only the difference defined by the IDF
criteria reached statistical significance. On the other
hand, although both criteria demonstrated that people
without MS had a higher percentage of left ventricular
hypertrophy than those with MS, only the difference
defined by the BHP criteria reached statistical signifi-
cance. In contrast, for smoking and atrial fibrillation,
the IDF criteria showed that the values were higher in
people with MS than those without MS, while the BHP
criteria demonstrated that the values were higher in
people without MS, compared with those with MS. How-
ever, only the difference of smoking defined by the
IDF criteria reached statistical significance.
When sex was considered, for men determined by
the BHP criteria, only diabetes was significantly higher
and left ventricular hypertrophy was significantly lower
in the persons with MS, compared with non-MS (Table 3).
For men with MS as determined by the IDF criteria, in
addition to diabetes and left ventricular hypertrophy,
angina and myocardial infarction were also significantly
higher (Table 4). For women with MS, both the BHP and
IDF criteria defined significantly more angina, diabetes
and prior stroke/transient ischemic attack (Tables 3
and 4). On the other hand, only the BHP criteria, but not
the IDF criteria, defined a higher percentage of con-
gestive heart failure (Tables 3 and 4).
The 10-year probability of stroke of the study sam-
ple as estimated from the Framingham equation is
shown in Table 5. For both criteria, as a whole, patients
with MS had a higher 10-year probability of stroke com-
pared with non-MS (BHP criteria, 0.153 vs. 0.133; IDF
criteria, 0.159 vs. 0.132; both p < 0.001). However, the
differences were unequally contributed by the sexes.
For men, regardless of the BHP or IDF criteria, the prob-
ability of stroke did not differ significantly between
those with MS and those without MS. In contrast, in
women for both criteria, those with MS had higher risk
compared with those without MS (both p < 0.001).
Discussion
In this study, we showed that in our outpatient hyper-
tensive population seeking care from hospitals and
aged 55–80 years, the prevalence of MS defined by 
the current BHP criteria was 59.2%, which is nearly
twice as high as that of the general population of the
same age section in Taiwan as defined by different cri-
teria16. Hwang et al.16 reported that in the general pop-
ulation of Taiwan, based on a nationwide cross-sectional
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Table 2. Distribution of risk factors for stroke according to different criteria of metabolic syndrome (MS)*
BHP IDF
MS present MS absent 
p
MS present MS absent 
p
(n = 2,055) (n = 1,417) (n = 1,697) (n = 1,775)
CHF 168/2,003 (8.4) 94/1,377 (6.8) 0.10 134/1,651 (8.1) 128/1,729 (7.4) 0.44
Angina 435/1,996 (21.8) 246/1,380 (17.8) 0.005 381/1,646 (23.1) 300/1,730 (17.3) < 0.001
MI 124/1,999 (6.2) 71/1,381 (5.1) 0.19 120/1,648 (7.3) 75/1,732 (4.3) < 0.001
Diabetes 821/2,035 (40.3) 216/1,409 (15.3) < 0.001 647/1,678 (38.6) 390/1,766 (22.1) < 0.001
Smoking 271/2,051 (13.2) 204/1,413 (14.4) 0.30 291/1,692 (17.2) 184/1,772 (10.4) < 0.001
Murmur 156/2016 (7.7) 100/1,393 (7.2) 0.54 133/1,663 (8.0) 123/1,746 (7.0) 0.29
LVH 106/2,055 (5.2) 99/1,417 (7.0) 0.02 88/1,697 (5.2) 117/1,775 (6.6) 0.08
AF 73/2,046 (3.6) 52/1,402 (3.7) 0.83 64/1,693 (3.8) 61/1,755 (3.5) 0.63
Prior CVA/TIA 441/2,027 (21.8) 273/1,397 (19.5) 0.12 410/1,670 (24.6) 304/1,754 (17.3) < 0.001
*Data presented as n (%). CHF = congestive heart failure; MI = myocardial infarction; LVH = left ventricular hypertrophy; AF = atrial fibrillation;
CVA = cerebrovascular disease; TIA = transient ischemic attack.
population-based survey in 2002, the prevalence of
MS, defined by either criteria of modified Adult
Treatment Panel III, the Taiwan criteria updated in
2004 or the IDF criteria for Chinese, for each 10-year
interval from 50 to 79 years is 21.9–41.4% for women
and 19.5–33.3% for men. Consistent with the nation-
wide survey, the prevalence of MS in women in the
present study is higher compared with that in men. 
A higher prevalence in women is also reported in two
other large-scale cohorts investigating adults in differ-
ent Taiwan communities5,17 In contrast, a screening
program recruiting residents aged 40 years or older in
another Taiwan community showed that the preva-
lence of MS is lower in women18. On the other hand,
the prevalence of MS defined by the current BHP crite-
ria is lowered by 10.3% (from 59.2% to 48.9%) and the
ratio between sexes reversed by the IDF criteria, which
increased the prevalence of men by less than 10%
(from 52.5% up to 61.3%) but markedly decreased that
in women by 30% (from 66.1% down to 36.1%).
Nevertheless, in the present study, although both
BHP and IDF criteria consistently showed that a higher
percentage of individuals with MS had a history of
stroke and/or transient ischemic attack than those with-
out MS, only the difference defined by the IDF reached
statistical significance. When sex is considered, only
women with MS had a significantly higher percentage
of history of stroke and/or transient ischemic attack,
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Table 3. Sex-specific distribution of risk factors for stroke according to the definition of metabolic syndrome (MS) for
Taiwanese*
Men Women
MS present MS absent
p
MS present MS absent
p
(n = 925) (n = 838) (n = 1,130) (n = 579)
CHF 63/901 (7.0) 60/811 (7.4) 0.75 105/1,102 (9.5) 34/566 (6.0) 0.01
Angina 205/898 (22.8) 157/814 (19.3) 0.07 230/1,098 (20.9) 89/566 (15.7) 0.01
MI 82/839 (9.8) 57/814 (7.0) 0.11 42/1,100 (3.8) 14/567 (2.5) 0.15
Diabetes 361/917 (39.4) 135/831 (16.2) < 0.001 460/1,118 (41.1) 81/578 (14.0) < 0.001
Smoking 249/924 (26.9) 199/834 (23.9) 0.14 22/1,127 (2.0) 5/579 (0.9) 0.09
Murmur 68/907 (7.5) 62/820 (7.6) 0.96 88/1,109 (7.9) 38/573 (6.6) 0.34
LVH 46/925 (5.0) 69/838 (8.2) 0.006 60/1,130 (5.3) 30/579 (5.2) 0.91
AF 38/924 (4.1) 40/829 (4.8) 0.47 35/1,122 (3.1) 12/573 (2.1) 0.22
Prior CVA/TIA 264/910 (29.0) 218/823 (26.5) 0.24 177/1,117 (15.8) 55/574 (9.6) < 0.001
*Data are presented as n (%). CHF= congestive heart failure; MI=myocardial infarction; LVH= left ventricular hypertrophy; AF=atrial fibrillation;
CVA = cerebrovascular disease; TIA = transient ischemic attack.
Table 4. Sex-specific distribution of risk factors according to the definition of metabolic syndrome (MS) for Japanese*
Men Women
MS present MS absent 
p
MS present MS absent 
p
(n = 1,080) (n = 683) (n = 617) (n = 1,092)
CHF 74/1,050 (7.0) 49/662 (7.4) 0.78 60/601 (10.0) 79/1,067 (7.4) 0.07
Angina 242/1,048 (23.1) 120/664 (18.1) 0.01 139/598 (23.2) 180/1,066 (16.9) 0.002
MI 96/1,049 (9.2) 43/664 (6.5) 0.048 24/599 (4.0) 32/1,068 (3.0) 0.27
Diabetes 389/1,071 (36.3) 107/677 (15.8) < 0.001 258/607 (42.5) 283/1,089 (26.0) < 0.001
Smoking 279/1,078 (25.9) 169/680 (24.9) 0.63 12/614 (2.0) 15/1,092 (1.4) 0.36
Murmur 78/1,057 (7.4) 52/670 (7.8) 0.77 55/606 (9.1) 71/1,076 (6.6) 0.06
LVH 57/1,080 (5.3) 58/683 (8.5) 0.008 31/617 (5.0) 59/1,092 (5.4) 0.74
AF 45/1,078 (4.2) 33/675 (4.9) 0.48 19/615 (3.1) 28/1,080 (2.6) 0.55
Prior CVA/TIA 308/1,064 (28.9) 174/669 (26.0) 0.18 102/606 (16.8) 130/1,085 (12.0) 0.005
*Data are presented as n (%). CHF = congestive heart failure; MI = myocardial infarction; LVH = left ventricular hypertrophy; AF = atrial fibrilla-
tion; CVA = cerebrovascular disease; TIA = transient ischemic attack.
compared with those without MS, regardless of either
criteria. Such a sex difference also existed in the prob-
ability of risk for stroke predicted by the Framingham
equation. The increased predicted risk for stroke in pa-
tients with MS shown in the present study is in accor-
dance with two recent reports based on more than 
10 years’ follow-up in Taiwan communities, one of
which demonstrated a hazard ratio of 4.3 for ischemic
stroke17 and the other revealed of 2.1 for ischemic and
non-ischemic stroke5. However, unlike the sex-specific
difference in the probability of risk for stroke predicted
in the present study, in both the mentioned reports,
the presence of MS defined according to the original
National Cholesterol Education Program–Adult Treat-
ment Panel III criteria increased both sexes’ risk for
stroke and the risk in men is more than 1.5-fold that of
women5.
The individuals studied here, hypertensive patients
aged 55–80 years, represent a substantial portion of
the general population in Taiwan within this age range,
given that 34.1% of the population is aged 35–64 years
and 58.1% of the population aged older than 64 years
had hypertension, as revealed by the nationwide sur-
vey19. Although participants in the present study were
all hypertensive, the high prevalence of MS is not only
attributed to the existence of hypertension. Compared
with the data from the nationwide survey, the preva-
lence of central obesity in the present study exceeds that
of the general population by approximately 20%16,
based on the same cutoff point of ≥ 90 cm in men and
≥ 80 cm in women. In addition, the percentage of
women with HDL-cholesterol < 50 mg/dL in the pres-
ent study is more than twice that in our general popu-
lation of the same age range20.
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Table 5. Ten-year probability of stroke estimated from the Framingham equation according to different criteria of metabolic
syndrome (MS)
Criteria MS Non-MS p
BHP criteria for Taiwanese
Total < 0.001
n 1,599 1,124
Mean ± SD 0.153 ± 0.115 0.133 ± 0.105
95% CI (0.147, 0.158) (0.127, 0.139)
Men 0.21
n 652 607
Mean ± SD 0.168 ± 0.101 0.160 ± 0.109
95% CI (0.160, 0.175) (0.151, 0.169)
Women < 0.001
n 947 517
Mean ± SD 0.143 ± 0.124 0.102 ± 0.091
95% CI (0.135, 0.151) (0.094, 0.110)
IDF criteria for Japanese
Total < 0.001
n 1,273 1,450
Mean ± SD 0.159 ± 0.109 0.132 ± 0.112
95% CI (0.153, 0.165) (0.127, 0.138)
Men 0.29
n 761 498
Mean ± SD 0.167 ± 0.100 0.160 ± 0.112
95% CI (0.159, 0.174) (0.150, 0.170)
Women < 0.001
n 512 952
Mean ± SD 0.147 ± 0.121 0.118 ± 0.110
95% CI (0.137, 0.158) (0.111, 0.125)
BHP = Bureau of Health Promotion; SD = standard deviation; CI = confidence interval; IDF = International Federation of Diabetes.
The findings of the present study have clinical impli-
cations. In Taiwan, cerebrovascular disease has been
one of the three leading causes of death in the past
four decades and has constituted a huge economic
burden21. Since 1995, the health expenditure has been
reimbursed mainly by the National Health Insurance
under a restricted global budget policy. Because the aim
to treat hypertension is to prevent the occurrence of
future cardiovascular events and, in the present study,
women with MS possess higher risk than those without,
regardless of the definition, female MS patients may
be a target for population-based risk factor modification
strategies, which may in turn reduce their projected
risk of stroke and reduce stroke costs to the National
Health Insurance in Taiwan. In addition, diagnosis and
management of MS and its related diseases demand
major health expenditure. From the findings of the pres-
ent study, the IDF criteria defines MS 30% less (BHP,
66.1%; IDF, 36.1%) in women, but the 10-year proba-
bility for stroke only increases by 0.4% (BHP, 14.3%;
IDF, 14.7%), compared with the current BHP definition.
Therefore, the IDF criteria should be more cost-effective
in terms of treating the female population studied here.
In contrast, for men, both MS criteria gave rather simi-
larly predicted stroke risk for MS and non-MS, and are
not helpful for stroke risk stratification.
On the other hand, for each risk factor for cardiovas-
cular disease examined in the present study, the per-
centage distribution in people with MS is not always
higher than those without MS, regardless of whether the
BHP or IDF criteria was used. For example, heart failure
in men, which is known to be more common in obese
people22, was not higher in men with MS than in those
without MS. Some risk factors were even seen more fre-
quently in patients without MS, such as left ventricular
hypertrophy, compared with those with MS. This sug-
gests that the increased cardiovascular risk associated
with MS is not evenly caused by the traditional risk
factors.
One limitation of the present study is that the
Framingham equation for stroke was developed from
data collected over 36 years of follow-up in the general
population sample at Framingham, Massachusetts, USA.
The risk equation has not been validated in an elderly,
hypertensive Taiwanese patient population. More recent
collection of the follow-up clinical data of all the par-
ticipants in the present study would be helpful.
In conclusion, hypertensive people aged 55–80 years
in Taiwan have a high prevalence of MS, as defined by
either the current BHP criteria for Taiwanese or the IDF
criteria for Japanese. With the use of the Framingham
equation for stroke, both criteria consistently showed
that the females in the population with MS have a
higher risk for stroke, compared with those without
MS. These findings suggest that the definition of MS is
promising for risk stratification of stroke in our elderly
hypertensive women.
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Hsiu-Fen Lin (Chung-Ho Memorial Hospital, Kaohsiung
Medical University), Jih-Min Lin (Keelung Hospital,
Department of Health, Executive Yuan), Min-Ren Lin
(Tainan Hospital, Department of Health, Executive
Yuan), Ruey-Tay Lin (Chung-Ho Memorial Hospital,
Kaohsiung Medical University), Zi-Xing Lin (Lin Shin
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Hospital), An-Bang Liu (Buddhist Tzu Chi General Hos-
pital), Chung-Hsian Liu (China Medical University Hos-
pital), Yan-Ming Liu (Chutung Veterans Hospital),
Hung-Shun Lo (Cathay General Hospital), Helen L. Po
(Mackay Memorial Hospital), Kwo-Chang Ueng (Chung
Shan Medical University Hospital), Xin-Fan Wang
(Tung’s Taichung MetroHarbor Hospital), Jung-Chou
Wu (PingTung Christian Hospital), Ping-Chang Yang
(Pao Chien Hospital), and Hung-I Yeh (Mackay Memorial
Hospital). Statistical support by Miss Ya-Chuan Wang
(MSD Taiwan) is highly appreciated.
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